Impact on Major Life-changing Decisions in Patients with Atopic Dermatitis
DOI:
https://doi.org/10.2340/actadv.v105.42241Keywords:
atopic dermatitis, major life-changing decisions, quality of lifeAbstract
Atopic dermatitis (AD) is a chronic skin disease that significantly affects patients’ quality of life. While other dermatological conditions like psoriasis are known to impact major life-changing decisions (MLCD), no prior studies have evaluated this in AD. A descriptive cross-sectional study was conducted in patients with AD of at least 6 months’ duration. Sociodemographic and clinical characteristics of the patients, as well as severity from both the physician’s and patient’s point of view, were assessed using different rating scales such as the Eczema Area and Severity Index (EASI). Subsequently, patients were divided according to disease severity into severe AD (EASI ≥ 21) or mild–moderate AD (EASI < 21). Life decisions were evaluated across several areas, including work, education, social life, reproduction, recreation, housing, and lifestyle, using a 4-point Likert scale. A total of 104 patients, with an average disease duration of 20.36 years, were included. The results showed significant MLCD impairment, especially in clothing choices (52.9%), lifestyle (48.1%), and sports activities (41.4%). Severe AD was associated with greater social and emotional challenges, such as difficulties in social interactions (48.6% vs 26.1%) and romantic relationships (48.5% vs 18.8%) compared with mild–moderate AD. These findings highlight the profound impact of AD on daily life, emphasizing the need for comprehensive management strategies that address physical, psychological, and social aspects.
Downloads
References
Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 2015; 66: 8–16.
https://doi.org/10.1159/000370220 DOI: https://doi.org/10.1159/000370220
Montero-Vilchez T, Rodriguez-Pozo J-A, Diaz-Calvillo P, Salazar-Nievas M, Tercedor-Sanchez J, Molina-Leyva A, et al. Dupilumab improves skin barrier function in adults with atopic dermatitis: a prospective observational study. J Clin Med 2022; 11: 3341.
https://doi.org/10.3390/jcm11123341 DOI: https://doi.org/10.3390/jcm11123341
Ortiz de Frutos FJ, Torrelo A, de Lucas R, González MA, Alomar A, Vera Á, et al. Patient perspectives on triggers, adherence to medical recommendations, and disease control in atopic dermatitis: the DATOP Study. Actas Dermosifiliogr 2014; 105: 487–496. DOI: https://doi.org/10.1016/j.adengl.2014.04.012
https://doi.org/10.1016/j.ad.2014.01.004 DOI: https://doi.org/10.1016/j.ad.2014.01.004
Bylund S, Kobyletzki L, Svalstedt M, Svensson. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol 2020; 100: adv00160.
https://doi.org/10.2340/00015555-3510 DOI: https://doi.org/10.2340/00015555-3510
Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol 2014; 150: 593–595.
https://doi.org/10.1001/jamadermatol.2013.10271 DOI: https://doi.org/10.1001/jamadermatol.2013.10271
Ali F, Vyas J, Finlay A. Counting the burden: atopic dermatitis and health-related quality of life. Acta Derm Venereol 2020; 100: adv00161.
https://doi.org/10.2340/00015555-3511 DOI: https://doi.org/10.2340/00015555-3511
Bhatti Z, Salek M, Finlay A. Chronic diseases influence major life changing decisions: a new domain in quality of life research. J R Soc Med 2011; 104: 241–250.
https://doi.org/10.1258/jrsm.2011.110010 DOI: https://doi.org/10.1258/jrsm.2011.110010
Sanchez-Diaz M, Díaz-Calvillo P, Soto-Moreno A, Molina-Leyva A, Arias-Santiago S. Factors influencing major life-changing decisions in patients with psoriasis: a cross-sectional study. Acta Derm Venereol 2023; 103: adv11640.
https://doi.org/10.2340/actadv.v103.11640 DOI: https://doi.org/10.2340/actadv.v103.11640
Bhatti ZU, Salek K, Finlay AY. Concept of major life-changing decisions in life course research. In Kimball AB, Linder MD, editors. Basel: Karger, 2013: p. 52–66.
https://doi.org/10.1159/000350389 DOI: https://doi.org/10.1159/000350389
Bhatti ZU, Finlay AY, Bolton CE, George L, Halcox JP, Jones SM, et al. Chronic disease influences over 40 major life changing decisions (MLCDs): a qualitative study in dermatology and general medicine. J Eur Acad Dermatol Venereol 2014; 28: 1344–1355.
https://doi.org/10.1111/jdv.12289 DOI: https://doi.org/10.1111/jdv.12289
Bhatti ZU, Salek SS, Bolton CE, George L, Halcox JP, Jones SM, et al. The development and validation of the Major Life Changing Decision Profile (MLCDP). Health Qual Life Outcomes 2013; 11: 78.
https://doi.org/10.1186/1477-7525-11-78 DOI: https://doi.org/10.1186/1477-7525-11-78
Chopra R, Silverberg JI. Assessing the severity of atopic dermatitis in clinical trials and practice. Clin Dermatol 2018; 36: 606–615.
https://doi.org/10.1016/j.clindermatol.2018.05.012 DOI: https://doi.org/10.1016/j.clindermatol.2018.05.012
Reolid A, Servitje O, Ginarte M, Pérez-Ferriols A, Vélez A, Aragües M, et al. Validation of an optical pencil method to estimate the affected body surface area in psoriasis. Actas Dermosifiliogr 2020; 111: 143–148. DOI: https://doi.org/10.1016/j.adengl.2020.01.001
https://doi.org/10.1016/j.ad.2019.07.002 DOI: https://doi.org/10.1016/j.ad.2019.07.002
Simpson EL, de Bruin-Weller M, Eckert L, Whalley D, Guillemin I, Reaney M, et al. Responder threshold for Patient-Oriented Eczema Measure (POEM) and Children’s Dermatology Life Quality Index (CDLQI) in adolescents with atopic dermatitis. Dermatol Ther (Heidelb) 2019; 9: 799–805.
https://doi.org/10.1007/s13555-019-00333-2 DOI: https://doi.org/10.1007/s13555-019-00333-2
Pariser DM, Simpson EL, Gadkari A, Bieber T, Margolis DJ, Brown M, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin 2020; 36: 367–376.
https://doi.org/10.1080/03007995.2019.1699516 DOI: https://doi.org/10.1080/03007995.2019.1699516
Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom 2015; 84: 167–176.
https://doi.org/10.1159/000376585 DOI: https://doi.org/10.1159/000376585
Kelly KA, Balogh EA, Kaplan SG, Feldman SR. Skin disease in children: effects on quality of life, stigmatization, bullying, and suicide risk in pediatric acne, atopic dermatitis, and psoriasis patients. Children, 2021; 8: 1057.
https://doi.org/10.3390/children8111057 DOI: https://doi.org/10.3390/children8111057
Haeck IM, ten Berge O, van Velsen SGA, de Bruin-Weller MS, Bruijnzeel-Koomen CAFM, Knol MJ. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2012; 26: 236–241.
https://doi.org/10.1111/j.1468-3083.2011.04043.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04043.x
Holm JG, Agner T, Clausen M-L, Thomsen SF. Quality of life and disease severity in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2016; 30: 1760–1767.
https://doi.org/10.1111/jdv.13689 DOI: https://doi.org/10.1111/jdv.13689
Kim DH, Li K, Seo SJ, Jo SJ, Yim HW, Kim CM, et al. Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci 2012; 27: 1327.
https://doi.org/10.3346/jkms.2012.27.11.1327 DOI: https://doi.org/10.3346/jkms.2012.27.11.1327
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults. Ann Allergy Asthma Immunol 2018; 121: 340–347.
https://doi.org/10.1016/j.anai.2018.07.006 DOI: https://doi.org/10.1016/j.anai.2018.07.006
Drucker AM. Atopic dermatitis: burden of illness, quality of life, and associated complications. Allergy Asthma Proc 2017; 38: 3–8.
https://doi.org/10.2500/aap.2017.38.4005 DOI: https://doi.org/10.2500/aap.2017.38.4005
Birdi G, Cooke R, Knibb RC. Impact of atopic dermatitis on quality of life in adults: a systematic review and meta-analysis. Int J Dermatol 2020; 59 434–447.
https://doi.org/10.1111/ijd.14763 DOI: https://doi.org/10.1111/ijd.14763
Lundin S, Bergström A, Wahlgren CF, Johansson EK, Andersson N, Ballardini N, et al. Living with atopic dermatitis as a young adult in relation to health-related quality of life and healthcare contacts: a population-based study. Acta Derm Venereol 2022; 102: adv00702.
https://doi.org/10.2340/actadv.v102.294 DOI: https://doi.org/10.2340/actadv.v102.294
Ferrucci SM, Tavecchio S, Angileri L, Surace T, Berti E, Buoli M. Factors associated with affective symptoms and quality of life in patients with atopic dermatitis. Acta Derm Venereol 2021; 101: adv00590.
https://doi.org/10.2340/00015555-3922 DOI: https://doi.org/10.2340/00015555-3922
Misery L, Seneschal J, Corgibet F, Halioua B, Marquié A, Merhand S, et al. Impact of atopic dermatitis on patients and their partners. Acta Derm Venereol 2023; 103: adv5285.
https://doi.org/10.2340/actadv.v103.5285 DOI: https://doi.org/10.2340/actadv.v103.5285
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Lucia Fuentes-Barragán, Carmen García-Moronta, Raquel Sanabria-de la Torre, Francisco Javier León-Pérez, Alejandro Molina-Leyva, Salvador Arias-Santiago, Trinidad Montero-Vílchez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
